Posts Categorized: News
Interface Biologics's (IBI) antithrombogenic additive have been used in a new line of FDA-approved "breakthrough" dialysis products made by IBI's partner, Fresenius Medical Care.
Professor Milica Radisic (Institute of Biomaterials and Biomedical Engineering, Chemical Engineering), Professor Boyang Zhang (IBBME Alumni), and Dr. Yimu Zhao (Chemical Engineering, IBBME) had been awarded the 2019 Innovation & Commercialization Award by Tissue Engineering International & Regenerative Medicine Society (TERMIS).
Accounting for sex differences could be key for the development of better treatments as drug shows promise for brain repair in females only.
Multidisciplinary team awarded five year, $1M project grant to develop a new filling material
This U of T Engineering innovation makes implants safer, and is attracting new investment to Toronto
Global chemical company Evonik will maintain presence in Toronto after acquiring part of U of T spinoff Interface Biologics, Inc.
Dr. Margaret Hai-Ling Cheng, Naomi Matsuura, and José Zariffa were promoted to the Associate Professor rank, and Dr. Julie Audet was promoted to the Professor rank.
In a new study published in the Proceedings of the National Academy of Sciences, researchers in the lab of Professor Aaron Wheeler have demonstrated a novel and non-invasive way to manipulate cells through microrobotics.
Professors Milos Popovic (IBBME) and alumni Jeffrey Karp (IBBME PhD 0T4) are two IBBME members inducted as fellows of the Canadian Academy of Engineering (CAE).
Toronto-based entrepreneur Zaid Atto receives FACIT’s Ernsting Entrepreneurship Award to further develop his new device for safer and less invasive surgeries
Macrophages may respond to mechanical signals sent out by fibroblasts during wound repair.
Showing 361 - 370 of 586 results